The Enroll-HD RNA collection initiative is now active!

This initiative aims to create a high-quality, longitudinal RNA collection from at least 3,000 people with HD. Individuals across all stages of the disease life-course will be included, with a primary focus on premanifest and early manifest participants. Each participant will be followed up over a period of five years.

The first blood sample gathered under this initiative was collected from an Enroll-HD participant on Feb 28, 2024, at the George Huntington Institute in Muenster, Germany.

Congratulations and thank you to all those whose work made it possible to achieve this important milestone in HD research.